Trial NCT05653427

View at ClinicalTrials.gov 
Org. Study IDs: CR109249
Secondary IDs: 61186372HCC2001

Last trial update was posted on 2023-12-07

MeSH Interventions

Amivantamab-vmjw

MeSH Conditions

Carcinoma Carcinoma, Hepatocellular

Other Conditions


Stopping Reasons

N~15 subjects data analysis did not meet statistical consideration of ORR and study primary/secondary objectives were not met. Enrollment was terminated for futility

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID